SK133399A3 - Novel pyridine derivatives and pharmaceutical compositions containing them - Google Patents

Novel pyridine derivatives and pharmaceutical compositions containing them Download PDF

Info

Publication number
SK133399A3
SK133399A3 SK1333-99A SK133399A SK133399A3 SK 133399 A3 SK133399 A3 SK 133399A3 SK 133399 A SK133399 A SK 133399A SK 133399 A3 SK133399 A3 SK 133399A3
Authority
SK
Slovakia
Prior art keywords
pyridin
hydroxy
phenyl
butoxy
methyl
Prior art date
Application number
SK1333-99A
Other languages
English (en)
Slovak (sk)
Inventor
David Cheshire
David Cladingboel
Martin Cooper
David Hardern
Simon Hirst
Carol Manners
Michael Stocks
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9701194A external-priority patent/SE9701194D0/xx
Priority claimed from SE9702200A external-priority patent/SE9702200D0/xx
Priority claimed from SE9704402A external-priority patent/SE9704402D0/xx
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of SK133399A3 publication Critical patent/SK133399A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SK1333-99A 1997-04-01 1998-03-27 Novel pyridine derivatives and pharmaceutical compositions containing them SK133399A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9701194A SE9701194D0 (sv) 1997-04-01 1997-04-01 Novel compounds
SE9702200A SE9702200D0 (sv) 1997-06-09 1997-06-09 Novel compounds
SE9704402A SE9704402D0 (sv) 1997-11-28 1997-11-28 Novel compounds
PCT/SE1998/000575 WO1998043971A1 (en) 1997-04-01 1998-03-27 Novel pyridine derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
SK133399A3 true SK133399A3 (en) 2000-05-16

Family

ID=27355867

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1333-99A SK133399A3 (en) 1997-04-01 1998-03-27 Novel pyridine derivatives and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US6143751A (de)
EP (1) EP0984961B1 (de)
JP (1) JP2001517228A (de)
KR (1) KR20010005840A (de)
CN (1) CN1258296A (de)
AR (1) AR012216A1 (de)
AT (1) ATE202351T1 (de)
AU (1) AU6861198A (de)
BR (1) BR9808447A (de)
CA (1) CA2284597A1 (de)
DE (1) DE69800970T2 (de)
DK (1) DK0984961T3 (de)
EE (1) EE9900435A (de)
ES (1) ES2159943T3 (de)
GR (1) GR3036638T3 (de)
ID (1) ID23163A (de)
IL (1) IL131854A0 (de)
NO (1) NO994764D0 (de)
PL (1) PL335884A1 (de)
PT (1) PT984961E (de)
SK (1) SK133399A3 (de)
TR (1) TR199902433T2 (de)
WO (1) WO1998043971A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140844A1 (de) * 1999-01-08 2001-10-10 Vertex Pharmaceuticals Incorporated Verfahren zur herstellung von zwischenprodukten nützlich für die herstellung von arzneimitteln
CA2314458A1 (en) 1999-08-02 2001-02-02 Kazumi Okuro Process for production of 3-(3-pyridyl)-1-propanol derivatives
US6376524B1 (en) 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
CA2788587C (en) 2010-02-03 2020-03-10 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
KR20150023722A (ko) 2012-06-12 2015-03-05 애브비 인코포레이티드 피리디논 및 피리다지논 유도체
MA44674B1 (fr) 2016-04-15 2020-06-30 Abbvie Inc Inhibiteurs de bromodomaine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7955287A (en) * 1986-10-14 1988-04-21 G.D. Searle & Co. Pyridine derivatives
EP0264114A1 (de) * 1986-10-16 1988-04-20 G.D. Searle & Co. Alpha-[(phenylmethoxy)-methyl]-pyridinalkanol-Derivate
EE9800172A (et) * 1995-12-06 1998-12-15 Astra Pharmaceuticals Limited Ühendid

Also Published As

Publication number Publication date
DK0984961T3 (da) 2001-09-17
NO994764L (no) 1999-09-30
JP2001517228A (ja) 2001-10-02
TR199902433T2 (xx) 2000-04-21
AU6861198A (en) 1998-10-22
IL131854A0 (en) 2001-03-19
EE9900435A (et) 2000-04-17
AR012216A1 (es) 2000-09-27
EP0984961A1 (de) 2000-03-15
GR3036638T3 (en) 2001-12-31
DE69800970T2 (de) 2002-04-04
KR20010005840A (ko) 2001-01-15
ID23163A (id) 2000-03-23
BR9808447A (pt) 2000-05-23
WO1998043971A1 (en) 1998-10-08
PL335884A1 (en) 2000-05-22
DE69800970D1 (de) 2001-07-26
EP0984961B1 (de) 2001-06-20
CN1258296A (zh) 2000-06-28
PT984961E (pt) 2001-11-30
ES2159943T3 (es) 2001-10-16
ATE202351T1 (de) 2001-07-15
US6143751A (en) 2000-11-07
CA2284597A1 (en) 1998-10-08
NO994764D0 (no) 1999-09-30

Similar Documents

Publication Publication Date Title
US7671066B2 (en) Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
ES2218548T3 (es) Derivados de fenilo trisustituidos, utiles como inhibidores de la pde iv.
US7968724B2 (en) Ester derivatives as phosphodiesterase inhibitors
DE69405497T2 (de) Styryl-derivate, deren herstellung und verwendung als pde-iv inhibitoren
US10981891B2 (en) Antibacterial compounds and uses thereof
JPH02258766A (ja) 置換された2―ピリドン及びピリド―2―チオン、それらの製造方法、及び医薬におけるそれらの使用
CS402991A3 (en) Dichloroaniline derivatives, process of their preparation andpharmaceutical compositions comprising them
US6265409B1 (en) Pyridine derivatives and pharmaceutical compositions containing them
SK133399A3 (en) Novel pyridine derivatives and pharmaceutical compositions containing them
SK73998A3 (en) Compounds
SK130599A3 (en) Novel pyridine derivatives and pharmaceutical compositions containing them
JPH0331261A (ja) カルボン酸およびその誘導体
US7935688B2 (en) Vitamin D-like compound
AU6236799A (en) Novel compounds
CZ349999A3 (cs) Nové pyridinové deriváty a farmaceutické prostředky s jejich obsahem
WO2000018730A1 (en) Novel compounds
CZ343699A3 (cs) Nové pyridinové deriváty a farmaceutické prostředky s jejich obsahem
WO2000018731A1 (en) Novel compounds
MXPA01002293A (en) Novel compounds
MXPA99008489A (en) Novel pyridine derivatives and pharmaceutical compositions containing them